May it is then 2018, The quarterly will be out before then so will garnish more info on the Company position from that.
One year follow up data in patients from all three groups of the Phase IIb study will be announced in May 2018. To release data on patients in selected groups of that trial when all data are not available may falsely affect the outcome of those yet to reach the one year mark. The Board has also decided to continue follow-up until May 2019. 2019 ??
Still placing it all on NTcell, no updates on Diabecell , meeting with the Japanese JV partners etc, but i guess this mornings meeting was just a short one.
Ann: NTCELL and Parkinson's Clinical Trial Update, page-10
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $1.529K | 244.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 179444 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1964350 | 8 |
View Market Depth
| Last trade - 14.16pm 31/10/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |